Armata Pharmaceuticals, Inc. Common Stock (ARMP)
EBITDA Margin
-5121.82%
TTM · Period ending:
ARMP EBITDA Margin
Latest reported-5121.82%period ending
Latest reported-5121.82%period ending
ARMP TTM EBITDA Margin (-1733.33% → -5121.82%)
TTM ebitda margin
High-resolution chart · PNG
ARMP ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -1,109.0909% | |
| -2,700% | |
| -2,575% | |
| -3,366.6667% | |
| -2,350% | |
| -1,880% | |
| -1,820% | |
| -1,280% | |
| -2,425% | |
| -2,466.6667% | |
| -1,733.3333% | |
| -1,733.3333% |